Applications for Leave

Decision Information

Decision Content

No. 41087     

 

 

June 6, 2024

 

Le 6 juin 2024

 

 

 

 

BETWEEN:

 

Apotex Inc.

Applicant

- and -

 

Janssen Inc. and Actelion Pharmaceuticals Ltd.

Respondents

 

 

ENTRE :

 

Apotex Inc.

Demanderesse

- et -

 

Janssen Inc. et Actelion Pharmaceuticals Ltd.

Intimées

 

 

 

JUDGMENT

 

The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-131-22, 2023 FCA 220, dated November 9, 2023, is dismissed with costs.

 

 

 

JUGEMENT

 

La demande d’autorisation d’appel de l’arrêt de la Cour d’appel fédérale, numéro A-131-22, 2023 CAF 220, daté du 9 novembre 2023, est rejetée avec dépens.

 

 

 

 

C.J.C.

J.C.C.

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.